Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1668051

	registered interest
	date	07/11/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Prescription Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to help tackle inequalities in access to PrEP.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	511
	answer	answer is ministerial correction date of answer 16/11/2023 answer text <p>The HIV Action Plan Implementation Steering Group (ISG) is developing a roadmap to help guide our efforts to improve equitable access, uptake and use of pre-exposure prophylaxis (PrEP) to meet the needs of key populations at significant risk of HIV. This forms part of the group’s work to monitor and drive forward the implementation of the HIV Action Plan. The roadmap is expected to be made available by the HIV Action Plan ISG before the end of the year.</p><p> </p><p>HIV PrEP is routinely available in specialist sexual health services throughout the country since March 2020 and we have invested more than £34 million in PrEP in 2020/21 and 2021/22. PrEP funding has been fully included within the public health grant since 2022/23 and funds appointments and testing in sexual health services, whilst NHS England covers the costs of the drug itself. The PrEP monitoring and evaluation framework was published by the UK Health Security Agency in March 2022 and consists of a series of indicators to support local authorities and inform service improvement in PrEP commissioning and delivery, providing local areas with information that can help them address inequalities in uptake of PrEP.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 16/11/2023 13:34:15 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4775 label Biography information for Elliot Colburn

1668465

	registered interest
	date	08/11/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the oral statement from the Parliamentary Under-Secretary of State for Health and Social Care on Community Pharmacies, Official Report, Column 450WH, whether his Department's PrEP roadmap will include plans to make PrEP accessible (a) online, (b) in pharmacies and (c) in GPs surgeries.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	938
	answer	answer is ministerial correction date of answer 16/11/2023 answer text <p>The HIV Action Plan Implementation Steering Group (ISG) is developing a roadmap to help guide our efforts to improve equitable access, uptake and use of pre-exposure prophylaxis (PrEP) to meet the needs of key populations at significant risk of HIV. This forms part of the group’s work to monitor and drive forward the implementation of the HIV Action Plan.</p><p> </p><p>HIV PrEP is currently only prescribed at specialist sexual health services, but as we work towards our 2030 ambitions, we will explore opportunities for making it available in a variety of settings. The PrEP roadmap takes into consideration actions needed to improve HIV PrEP access pathways in settings other than specialist sexual health services, including online, general practitioner services and pharmacies, to enable potential future delivery in other settings. The roadmap is expected to be made available by the HIV Action Plan ISG before the end of the year.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 16/11/2023 13:09:52 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4775 label Biography information for Elliot Colburn

1673501

	registered interest
	date	28/11/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the oral contribution from the Parliamentary Under-Secretary of State for Health and Social Care during the Westminster Hall debate on Healthcare Services: Carshalton and Wallington on 23 May 2023, Official Report, Column 71WH, what progress her Department has made on producing a radical dentistry plan.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	4278
	answer	answer is ministerial correction date of answer 07/12/2023 answer text <p>We are working on our Dentistry Recovery Plan which will address how we continue to improve access, particularly for new patients; and how we make National Health Service work more attractive to ensure NHS dentists are incentivised to deliver more NHS care.</p><p>Our Dentistry Recovery Plan will build upon the first package of reforms agreed in July 2022, which included changes to banding and the introduction of a minimum Units of Dental Activity value. Our plan will include addressing how we continue to improve access, particularly for new patients; and how we make NHS work more attractive to ensure NHS dentists are incentivised to deliver NHS care.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 07/12/2023 14:26:49 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4775 label Biography information for Elliot Colburn

1686774

	registered interest
	date	01/02/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Genomics: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the availability of genomic testing.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	12685
	answer	answer is ministerial correction date of answer 09/02/2024 answer text <p>The National Genomic Test Directory defines which genomic tests must be delivered by the NHS Genomic Laboratory Hubs in England, as well as who is eligible for genomic testing. The directory currently covers testing for over 3,200 rare diseases and over 200 cancer clinical indications. NHS England regularly updates the directory, through a robust and evidence-based test evaluation process, to keep pace with scientific and technological advances, and to ensure that genomic testing is available for all patients for whom it would be of clinical benefit. Testing is available for all eligible patients across England.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 09/02/2024 10:40:07 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4775 label Biography information for Elliot Colburn

1686775

	registered interest
	date	01/02/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Genomics: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will take steps to ensure future NHS genomic testing publications include data on access to different cancer tests based on an individual's (a) ethnicity, (b) socioeconomic status and (c) type of cancer test.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	12686
	answer	answer is ministerial correction date of answer 08/02/2024 answer text <p>National Health Service genomic testing activity data, collected from all seven NHS Genomic Laboratory Hubs, is available on the NHS England website. NHS England will continue to publish this data on a quarterly basis. The published data indicates the total volume of genomic testing activity completed per month, broken down into cancer and rare and inherited disease. The cancer data is further separated into nine different categories of cancer. NHS England is looking into separating this further if there are other specific categories of cancer test type which would be of interest. The published data does not currently include data broken down by ethnicity or socioeconomic status, but NHS England’s ambition is to improve and expand future publications of the data, which may include areas relating to health inequalities.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 08/02/2024 15:27:18 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4775 label Biography information for Elliot Colburn

1686776

	registered interest
	date	01/02/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the implications for her policies of variations in access to genetic and genomic testing for cancer through the NHS Genomics Medicine Service; and what steps her Department is taking to reduce these variations.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	12687
	answer	answer is ministerial correction date of answer 08/02/2024 answer text <p>The seven NHS Genomic Medicine Service Alliances raise awareness of genomics among healthcare professionals and support delivery of equitable access to genomic testing, clinical genetics, and genomic counselling services. NHS England has also established the NHS Genomics Ethics, Equity and Legal Advisory Group to ensure that the NHS Genomic Medicine Service (NHS GMS) provides equitable access to all patients. The group will identify and review appropriate datasets to inform health inequalities analysis of the NHS GMS, and identify actions to address inequalities.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 08/02/2024 15:44:36 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4775 label Biography information for Elliot Colburn

1686779

	registered interest
	date	01/02/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the impact of trends in average waiting times for biomarker and genomic testing on waiting times for cancer treatment.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	12690
	answer	answer is ministerial correction date of answer 08/02/2024 answer text <p>NHS England has implemented capturing of Patient Level Contract Monitoring data across the National Health Service Genomic Laboratory Hubs (GLHs) to facilitate a national approach to reporting and validating activity data and turnaround times. This will enable NHS England to understand activity volumes, detect any backlogs, and institute recovery. NHS England undertakes a quarterly assurance process with each of the NHS GLHs to monitor improvements in turnaround times to ensure these are being met in every region and for all patients.</p><p>NHS England is also undertaking a programme of work alongside clinical experts, including the Medical Royal Colleges, to establish clinically relevant cancer turnaround times across diagnosis, prognosis, treatment determining clinical use cases and optimising cancer pathways to ensure genomic test results are provided in a clinically relevant timeframe.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 08/02/2024 15:33:11 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4775 label Biography information for Elliot Colburn

1689210

	registered interest
	date	16/02/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liver Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the report by the British Liver Trust entitled Liver Cancer – A Call to Action, published in October 2023, if she will make an assessment of the potential merits of implementing an optimal care pathway for liver cancer.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	14137
	answer	answer is ministerial correction date of answer 26/02/2024 answer text <p>The care of and treatment for patients with cancers, including liver cancer, is a priority for the Government. National Health Service cancer standards have been reformed with the support of clinicians to speed up diagnosis for patients, which means people will receive a diagnosis or have cancer ruled out within 28 days of urgent cancer referral from their general practice. NHS England’s Early Diagnosis of Cancer Programme is contributing to the NHS Long Term Plan’s commitment to diagnose 75% of all cancers at stage one or two by 2028. Identifying those at risk and ensuring patients are tested and referred to a surveillance programme, where necessary, will lead to improved patient outcomes.</p><p>The Government is taking steps through NHS England to improve outcomes for cancer patients, including liver cancer. Diagnostic checks are a key part of cancer pathways and the 153 community diagnostic centres (CDCs) opened by the Government will give earlier diagnostic tests, benefitting millions of patients including those who are referred with suspected less survivable cancers. NHS systems have been asked to prioritise CDC capacity towards their most challenged cancer pathways, where this is clinically appropriate, and these centres have delivered over six million additional tests for all elective activity since July 2021.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 26/02/2024 10:28:51 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4775 label Biography information for Elliot Colburn

1695115

	registered interest
	date	11/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential merits of (a) 3D mammography and (b) other new screening technologies to support the early diagnosis of breast cancer.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	17982
	answer	answer is ministerial correction date of answer 19/03/2024 answer text <p>The UK National Screening Committee (UK NSC) is aware of research into the use of three-dimensional (3D) mammography and the growing interest to use artificial intelligence (AI) in the National Health Service breast screening programme. Guidance has been published on GOV.UK on the use of Tomosynthesis 3D imaging in a clinical trial setting as part of the NHS breast screening programme.</p><p>The UK NSC had also worked with Health Technology Assessments to design an evaluation of existing AI in a prospective study to look at whether it could be used to read breast screening mammograms.</p><p>There are currently no plans to adopt these technologies, but evidence to inform a UK NSC decision on the use of 3D mammography and AI in the NHS breast screening programme will be reviewed by the Committee when available.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 19/03/2024 14:57:39 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4775 label Biography information for Elliot Colburn

1695116

	registered interest
	date	11/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of (a) lowering the breast cancer screening age to 40 and (b) including a breast cancer risk assessment in the first appointment.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Elliot Colburn
	uin	17983
	answer	answer is ministerial correction date of answer 19/03/2024 answer text <p>The UK National Screening Committee (UK NSC) currently recommends that all women aged 50 years old to 71 years old are invited for breast screening every three years. A trial, AgeX is looking at the impact of increasing or decreasing, or both, the screening age for the breast screening programme. When the results from this trial are available, the UK NSC will review the findings. The UK NSC plans to review the evidence for risk stratification in breast screening to tailor it more closely to an individual’s risk of cancer, rather than the current population-based approach.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 19/03/2024 15:37:13 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4775 label Biography information for Elliot Colburn